Trade Viatris Inc. - VTRS CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.09 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.026235% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004012% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 11.86 |
| Open | 11.91 |
| 1-Year Change | 21.65% |
| Day's Range | 11.83 - 12.07 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Sep 19, 2024 | 11.86 | -0.13 | -1.08% | 11.99 | 12.07 | 11.79 |
| Sep 18, 2024 | 11.86 | 0.10 | 0.85% | 11.76 | 11.97 | 11.65 |
| Sep 17, 2024 | 11.77 | 0.02 | 0.17% | 11.75 | 11.78 | 11.63 |
| Sep 16, 2024 | 11.76 | 0.05 | 0.43% | 11.71 | 11.77 | 11.51 |
| Sep 13, 2024 | 11.63 | -0.11 | -0.94% | 11.74 | 11.89 | 11.58 |
| Sep 12, 2024 | 11.71 | 0.38 | 3.35% | 11.33 | 11.72 | 11.31 |
| Sep 11, 2024 | 11.30 | 0.25 | 2.26% | 11.05 | 11.36 | 10.95 |
| Sep 10, 2024 | 11.12 | 0.00 | 0.00% | 11.12 | 11.14 | 10.80 |
| Sep 9, 2024 | 11.07 | -0.16 | -1.42% | 11.23 | 11.43 | 11.06 |
| Sep 6, 2024 | 11.22 | -0.45 | -3.86% | 11.67 | 11.73 | 11.11 |
| Sep 5, 2024 | 11.62 | -0.15 | -1.27% | 11.77 | 11.85 | 11.60 |
| Sep 4, 2024 | 11.73 | -0.13 | -1.10% | 11.86 | 11.86 | 11.68 |
| Sep 3, 2024 | 11.84 | -0.03 | -0.25% | 11.87 | 11.95 | 11.80 |
| Aug 30, 2024 | 12.05 | 0.15 | 1.26% | 11.90 | 12.05 | 11.89 |
| Aug 29, 2024 | 11.85 | -0.03 | -0.25% | 11.88 | 11.91 | 11.74 |
| Aug 28, 2024 | 11.86 | 0.22 | 1.89% | 11.64 | 11.88 | 11.61 |
| Aug 27, 2024 | 11.65 | 0.01 | 0.09% | 11.64 | 11.71 | 11.57 |
| Aug 26, 2024 | 11.71 | -0.01 | -0.09% | 11.72 | 11.81 | 11.66 |
| Aug 23, 2024 | 11.71 | 0.15 | 1.30% | 11.56 | 11.73 | 11.54 |
| Aug 22, 2024 | 11.66 | -0.05 | -0.43% | 11.71 | 11.77 | 11.61 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Viatris Inc. Company profile
Viatris (VTRS) is a global healthcare company. It was formed in 2020 through the merger of Pfizer’s (PFE) off-patent branded and generic medicines division Upjohn and pharmaceutical firm Mylan.
The merger of Mylan and Upjohn was announced in July 2019 and received final regulatory clearance in October 2020. Pfizer shareholders own 57% of Viatris and Mylan shareholders own 43%, according to the merger announcement. Viatris started trading on the Nasdaq Stock Exchange under the ticker VTRS in November 2020.
Viatris is headquartered in Canonsburg, Pittsburgh, US. The company is operational in over 165 countries and has global centres in Shanghai, China and Hyderabad, India.
Viatris operates about 40 manufacturing sites which produce oral solid doses, injectables, complex dosage forms and active pharmaceutical ingredients. The firm also produces numerous complex generics, biosimilars and global key brands.
Viatris offers treatment options across more than 10 major therapeutic areas covering a wide variety of non-communicable and infectious diseases. According to the company’s website, 50% of its total active pharmaceutical ingredient (API) capacity is devoted to antiretroviral (ARV), which is used against HIV infection.
Some of the well-known and key brands under Viatris are anxiety treatment drug Xanax, antidepressant Zoloft, anti-inflammatory drug Celebrex and erectile dysfunction therapy Viagra, among others. Viatris also offers global biosimilars franchises focused on the areas of oncology, immunology, endocrinology, ophthalmology and dermatology.
| Industry: | Pharmaceuticals (NEC) |
1000 Mylan Boulevard
CANONSBURG
PENNSYLVANIA 15317
US
News
BoE Preview: no change expected but forward guidance will be key
The BoE is forecasted to leave rates unchanged in September as UK CPI remains stubborn.
14:53, 19 September 2024
FOMC Decision Review: A 50 point cut but the markets responded in a mixed fashion
Discover the US Federal Reserve’s latest 50 basis point cut and how the markets reacted. Stocks surged, the US Dollar fell, and the Fed hints at more aggressive cuts ahead.
11:30, 19 September 2024
Bank of Japan Preview
The Bank of Japan will meet on September 20, 2024, with markets anticipating minimal policy changes. However, inflation risks remain, with core CPI at 2.7% and potential for future interest rate hikes.
09:40, 17 September 2024
FOMC Decision Preview
As the US Federal Reserve prepares for its most significant decision since ending the rate hike cycle in mid-2023, the balance of risks has shifted. With inflation stabilizing at 2.6% and rising unemployment at 4.2%, the FOMC faces increasing pressure to address employment concerns. Markets anticipate a rate cut, with debate on the extent of the reduction.
09:48, 16 September 2024
ECB Preview: cuts expected but the pace is uncertain
Markets expect the ECB to cut rates again in September, but how many more?
12:34, 11 September 2024
Market analysis: US CPI and PPI
Overview of upcoming US inflation data for August, with expectations for a year-over-year CPI drop to 2.6% and core CPI holding steady at 3.2%. Markets will also focus on U.S. PPI data, which is forecasted to show mild growth, reinforcing potential easing inflationary pressures.
07:56, 10 September 2024
Introducing Newsquawk: your new in-platform newsfeed
We are very excited to announce the launch of Newsquawk in the Capital.com platform and app. This new newsfeed is designed to help you get ahead with real-time headlines, personalised stories and in-depth reports – all available directly in the platform and app, where you need them.
14:09, 20 August 2024People also watch
Still looking for a broker you can trust?
Join the 640,000+ traders worldwide that chose to trade with Capital.com